Karyopharm Therapeutics shares are trading lower after an S-8 filing from the company showed registration for a 150K share common stock offering via selling shareholders. Also, multiple firms downgraded the stock following the company's Q2 earnings report yesterday premarket.

Never miss a trade again with the fastest news alerts in the world!

This headline only article is a sample of real-time intelligence Benzinga Pro traders use to win in the markets everyday.

Want the fastest, most accurate stock market intelligence? Want EXCLUSIVE stories originated by Benzinga reporters? Join 10,000+ serious traders in the Benzinga Pro community!